
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc. demonstrated strong financial performance with total revenue per Accountable Healthcare Services Client (AHSC) increasing by 5.6% year-over-year, driven by client expansions across its comprehensive suite of solutions. The company's patient payment volumes also grew 9.3% year-over-year, reaching $1.181 billion for the third quarter of FY26, reflecting continued growth from both new and existing clients. Additionally, Phreesia raised its FY26 adjusted EBITDA guidance to a range of $99 million to $101 million, indicating significant year-over-year growth of 172% and outperforming consensus estimates, alongside an anticipated increase in total revenue per AHSC for FY26.
Bears say
Phreesia Inc. reported 3Q26 revenue of $120.3 million, which was marginally below the expected $120.4 million, indicating potential challenges in revenue growth amidst a competitive landscape. Additionally, the company ended the quarter with 4,520 provider clients, falling short of consensus expectations and reflecting slower client acquisition, contributing to a negative outlook on its growth trajectory. Concerns also persist regarding the potential impact of another COVID-19 surge on patient visit volumes, which could further hinder Phreesia's topline growth and financial performance.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares